Company Data

Xenon Pharmaceuticals Inc.

Current Price
$34.72 1.02%
Market Cap
Price Target
Refer to Report
52wk Range
$23.26 - $41.39
Advanced Market Data


Xenon Pharmaceuticals Inc is a clinical stage biopharmaceutical company committed to developing innovative therapeutics to improve the lives of patients with neurological disorders, including rare central nervous system, or CNS, conditions. The product candidates of the group include XEN1101, XEN901 and XEN496 for Epilepsy, XEN007 for Orphan neurological and MAC1.7 inibitors for Pain. Geographically the activities are carried out through Canada.

Inbox Intel from Channelchek.

Informed investors make more money. And it’s all about timing. Get it when it happens.

By clicking submit you are agreeing to the Terms of Use and Privacy Policy
© 2018-2022 Noble Financial Group, Inc. All Rights Reserved. Channelchek is provided at no cost to be used for information purposes only and not as investment advisement.